Nuveen
BLTE icon

Nuveen’s Belite Bio BLTE Stock Holding History

Nuveen’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$59.5K Buy
+357
New +$57.9K ﹤0.01% 4152

Other funds holding BLTE

UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Patient Square Capital
Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Alberta Investment Management Corp (AIMCo)
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
High Net Worth Advisory Group
High Net Worth Advisory Group Naples, Florida $476M AUM 15.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dymon Asia Capital (Singapore)
Dymon Asia Capital (Singapore) Singapore $2.21B AUM 109.09% 1-Year Est. Return

Nuveen's BLTE Position: Q3 2026 in Review

Nuveen opened a new position in Belite Bio (BLTE) in Q3 2026: 357 shares worth $59.5K. The stake represents ﹤0.01% of the portfolio and ranks #4152 among its holdings.

23 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Nuveen held 357 shares of Belite Bio worth $59.5K as of Q3 2026.
  • Belite Bio was a new Nuveen position in Q3 2026.
  • Belite Bio made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4152 holding.
  • 23 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.